1 post • Page 1 of 1
Chemotherapy - Acute Myelogenous LeukemiaChemotherapy - Acute Myelogenous Leukemia (AML) The most common drug treatment plan used to treat AML is the combination of 3 days of an anthracycline (e.g., daunorubicin, doxorubicin) and 7 days of ara-C. This plan is known as the three-plus-seven method. Some oncologists also add the drug 6-thioguanine to the mix (see option 2), although most studies indicate that this agent does not improve the rates or length of remission. Please Note: The option number does not imply that ...Read the full article
1 post • Page 1 of 1
|
|||||||



